Percent free prostate-specific antigen after radiotherapy for prostate cancer - 8 to 10 ng/mL total PSA

By Crook J.M.   Bunting P.S.  

Urology, Vol. 52, Iss. 1, 1998-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Digital rectal examination and prostate-specific antigen abnormalities at the time of prostate biopsy and biopsy outcomes, 1980 to 1997

By Roberts R.O.   Bergstralh E.J.   Lieber M.M.   Jacobsen S.J.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 817-822

Elsevier

Access to resources Recommend Favorite

The appropriate lower limit for the percent free prostate-specific antigen reflex range - assay of the complex improves clinical sensitivity for cancer

By Carlson G.D.   Calvanese C.B.   Childs S.J.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 450-454

Elsevier

Access to resources Recommend Favorite

Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting

By Keetch D.W.   Andriole G.L.   Ratliff T.L.   Catalona W.J.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 901-905

Elsevier

Access to resources Recommend Favorite

Kinetics of postbiopsy levels of serum free prostate-specific antigen and percent free prostate-specific antigen - studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin

By Lechevallier E.   Eghazarian C.   Ortega J.-C.   Daniel L.   Roux F.   Thirion X.   Coulange C.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 731-735

Elsevier

Access to resources Recommend Favorite